ASAndrew G. Shuman

Andrew G. Shuman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew G. Shuman has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Decision Making for Diagnosis and Management

    by Rebecca C. Hoesli, Andrew G. Shuman, Carol R. Bradford


  • Phase II prospective trial of cetuximab and radiotherapy for locally advanced, squamous cell carcinomas of the head and neck in patients >70 years old or with comorbidities not-eligible for platinum-based chemotherapy.

    by Paul Swiecicki, Matthew J Schipper, Kelly M Malloy, Chaz Stucken, Andrew G Shuman, Matthew E Spector, Douglas Brian Chepeha, Keith Casper, Scott A McLean, Jeffrey Moyer, et al.

    6071 Background: We designed a single arm phase II trial to determine the efficacy and toxicity of concurrent cetuximab (C) radiotherapy (RT) in patients non-eligible for standard chemotherapy. Non-eligibility was defined as age > 70 years (yrs), co-morbidities that preclude platinum-based chemotherapy, or creatinine clearance (CrCl) < 30 mL/min. Primary endpoint was progression free survival. Methods: 22 stage III/IVA patients (pts) were enrolled. The median age was 70 years (range: 40-85), 50% had eGFR with < 90 mL/min, 64% were males, 36% were females; 64% Caucasian, 36 % had an ECOG performance status (PS) of 0, 64% ECOG PS of 1. All pts received C 400 mg/m2 day (d) 0, then 250 mg/m2 d 7 and weekly during RT. Pts were treated with a planned 70 Gray (Gy) in 35 fractions over 7 weeks to the gross tumor and 50-60 Gy to subclinical target volumes.Results: As of January 2016 with a median follow up of 22.8 months and 22 evaluable pts, the median PFS was 30.07 months (95% CI: 2.93, > 50). The overall survival was 33.8 months (95% CI: 9.2, > 50). 6 pts (27%) have recurred, all of whom have died. Treatment related grade 3 toxicities were seen in 7 pts (32%), no grade 4 toxicities were seen. The most common grade 3 toxicities were mucositis (5 pts), dysphagia (4 pts), and dermatitis (3 pts). Conclusions: The results of this phase II prospective study suggest that in patients > 70 yrs old or with comorbidities, precluding platinum-based chemotherapy, tolerate treatment with C+RT well, though survival rates are lesser when compared with historical controls. Clinical trial information: NCT00904345.

  • A Surgeon's Dilemma

    by Andrew G. Shuman, Joseph J. Fins


  • Open Access

    Learning From Gus

    by Andrew G. Shuman


    • 1 January 2014
      • Vol. 77  (4)

    Bleeding by numbers. Rush versus Corbbett.

    by Andrew G Shuman, Marc Edelman, Joseph J Fins

  • Patching the Safety Net: Establishing a Free Specialty Care Clinic in an Academic Medical Center

    by Andrew G. Shuman, Oluseyi Aliu, Katherine Simpson, Paul Salow, Kara Morgenstern, Edward J. Jennings, Jean Cederna, Erin L. McKean, Carol R. Bradford, Paul S. Cederna

    We describe the collaboration between an academic medical center and a free primary care clinic that provides multi-specialty services to indigent community members. Complementary components of both institutions have engendered a system in which they broaden the array of available services, providing a prototype for other institutions to collaborate similarly.


  • Outcomes of a head and neck cancer screening clinic

    by Andrew G. Shuman, Janet T. McKiernan, Dorothy Thomas, Prateek Patel, Frank L. Palmer, Brian T. Shaffer, Jatin P. Shah, Snehal G. Patel, Jay O. Boyle


  • Implementation of a novel otolaryngology clinic for indigent patients

    by Andrew G. Shuman, Robbi Kupfer, Katherine Simpson, Jean Cederna, Paul S. Cederna, Paul Salow, Carol R. Bradford, Erin L. McKean

    Objectives/Hypothesis This study was designed to describe the implementation, utilization, and outcomes of an otolaryngology clinic for indigent patients employing a novel design. Study Design Pilot study. Methods A tertiary‐care academic otolaryngology department partnered with a nonprofit outpatient clinic for indigent patients in order to provide free subspecialty consultation services. A novel format was utilized in which the department provided on‐site, scheduled outpatient multidisciplinary consultation on weekends, staffed by volunteer health care providers and ancillary staff. A review of the program was conducted using prospectively collected data. Clinic design, staffing, utilization, and feasibility were described, along with demographic and clinical data for all patients participating in the clinic from October 2010 through January 2012. Results Five clinics were held over 15 months, totaling 74 patient visits, with positive feedback regarding accessibility and quality of services provided. A total of 60 procedures were performed, including audiograms, endoscopies, otologic procedures, biopsies and/or excisions. The estimated value of medical services that were provided was $37,302. Four potentially life‐threatening conditions were newly diagnosed. Twenty patients received conclusive evaluation and treatment at the time of their first visit. Eighteen patients required further subspecialty treatment and/or surgery that could not be provided in the outpatient setting, and were referred appropriately. Conclusions The partnership between an academic otolaryngology department and a nonprofit clinic provided free on‐site consultation for indigent patients. Such an arrangement is feasible, well utilized, and successful in delivering comprehensive specialized services to indigent patients who lack traditional access to medical care. Laryngoscope, 123:2142–2147, 2013


  • A new care paradigm in geriatric head and neck surgical oncology

    by Andrew G. Shuman, Beatriz Korc-Grodzicki, Victoria Shklar, Frank Palmer, Jatin P. Shah, Snehal G. Patel

    Background and Objectives Perioperative management of elderly patients with head and neck cancer poses unique challenges. Our objective is to describe the implementation and feasibility of a novel intervention designed to improve perioperative care in geriatric head and neck surgery. Methods This pilot study was performed in a single‐institution, NCI‐designated comprehensive cancer center. All surgical patients with head and neck cancer over age 75 were offered perioperative consultation with fellowship‐trained geriatricians focusing in geriatric oncology. Results Between 2010 and 2011, a total of 168 patients requiring head and neck surgery were seen by the geriatric service, of which 94% subsequently underwent surgery. Apart from preoperative medical optimization, geriatricians assisted in complex decision‐making regarding the indications for cancer‐directed therapy. Postoperatively, they assisted in preventing and treating delirium and poly‐pharmacy, facilitating discharge planning, and initiating rehabilitation. Postoperatively, 87% were discharged home, and 13% required placement in skilled nursing facilities. At 24 months, overall survival was 80%. Patients, surgeons and geriatricians alike were enthusiastic about the initiative, which is expanding within the institution. Conclusion Geriatric perioperative support for elderly head and neck cancer patients is well‐received with promising potential. The tangible impact and direct benefits of this pilot initiative require additional study. J. Surg. Oncol. 2013; 108:187–191.


  • Optimizing perioperative management of geriatric patients with head and neck cancer

    by Andrew G. Shuman, Snehal G. Patel, Jatin P. Shah, Beatriz Korc-Grodzicki

    Given emerging demographic trends, many more elderly patients are being diagnosed with head and neck cancers. The surgical care paradigm for this cohort of patients must take into account specific challenges inherent to geriatric perioperative management. This article attempts to summarize the existing body of literature relevant to the geriatric head and neck cancer population, and to extrapolate relevant data from geriatric perioperative medicine in order to better understand and guide management decisions. The involvement of geriatricians and of patients' primary care providers may be invaluable in assisting in complex perioperative decision‐making and in participating in longitudinal management. Preoperative risk stratification and assessment of medical, social, and functional variables are critical for appropriate decision‐making in this challenging patient population. © 2013 Wiley Periodicals, Inc. Head Neck 36: 743–749, 2014